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Osteopathia Striata with Cranial Sclerosis: Genetic Diagnosis in a Rural Setting
Abstract
Osteopathia striata with cranial sclerosis (OSCS) is a rare skeletal dysplasia inherited in an X-linked
dominant pattern. Patients present with a wide variety of congenital anomalies such as craniofacial,
cardiac, musculoskeletal, intestinal, and genitourinary abnormalities, and developmental delay. The
genetic mutation causes increased ossification of bones which can compress cranial nerves and
subsequently lead to acquired hearing loss, facial paralysis, and other neurologic defects. OSCS has also
been associated with epileptic seizures, pyloric stenosis, hypothyroidism, and increased bone fragility.
Due to the nonspecific presentation of conditions like OSCS and the serious complications it predisposes
patients to, it is important that children undergo early genetic testing to confirm the diagnosis of such
conditions. Genetic testing and similar services are especially limited in rural and underserved areas and
this significantly impacts patient care, particularly for the pediatric population. This case describes a child
with limited access to nearby genetic services presenting with multiple unexplained congenital
abnormalities who was ultimately diagnosed with OSCS following genetic testing. It describes the clinical
presentation of a rare condition and highlights the significantly protracted process of genetic testing for
patients in underserved areas without access to genetic services and why providers must be aware of
these healthcare disparities and how they affect patients.
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ABSTRACT
Osteopathia striata with cranial sclerosis (OSCS) is a rare skeletal dysplasia inherited in an
X-linked dominant pattern. Patients present with a wide variety of congenital anomalies such as
craniofacial, cardiac, musculoskeletal, intestinal, and genitourinary abnormalities, and
developmental delay. The genetic mutation causes increased ossification of bones which can
compress cranial nerves and subsequently lead to acquired hearing loss, facial paralysis, and other
neurologic defects. OSCS has also been associated with epileptic seizures, pyloric stenosis,
hypothyroidism, and increased bone fragility. Due to the nonspecific presentation of conditions
like OSCS and the serious complications it predisposes patients to, it is important that children
undergo early genetic testing to confirm the diagnosis of such conditions. Genetic testing and
similar services are especially limited in rural and underserved areas and this significantly impacts
patient care, particularly for the pediatric population. This case describes a child with limited
access to nearby genetic services presenting with multiple unexplained congenital abnormalities
who was ultimately diagnosed with OSCS following genetic testing. It describes the clinical
presentation of a rare condition and highlights the significantly protracted process of genetic
testing for patients in underserved areas without access to genetic services and why providers
must be aware of these healthcare disparities and how they affect patients.
Key words: congenital anomalies, access to care, healthcare disparities, genetic testing

INTRODUCTION
Osteopathia striata with cranial sclerosis (OSCS) is a rare skeletal dysplasia with a
prevalence rate of 0.1/1 million people worldwide (Savarirayan et al., 2012). It has been shown to
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be associated with a pathogenic variant in the AMER1 gene, also known as the WTX gene (Jenkins
et al., 2009), and is inherited in an X-linked dominant pattern (Behninger & Rott, 2000; Rott et al.,
2003; Viot et al., 2002). The pathogenic variant is a loss-of-function mutation which ultimately
leads to upregulated Wnt signaling promoting bone formation, which can result in cranial sclerosis
(Perdu et al., 2010). OSCS affects females to males in a 9:1 ratio and can be lethal in male fetuses
in utero (Viot et al., 2002). The lower male survivability rates can be explained due to the X-linked
nature of this gene. The term osteopathia striata refers to the radiologic findings of benign linear
striations that may be seen on long bones, bones of the pelvis, and scapulae in affected patients,
though affected males rarely have these striations (Perdu et al., 2010).
This condition can cause congenital defects including craniofacial abnormalities such as
hypertelorism and macrocephaly, and cardiac abnormalities such as atrial or ventricular septal
defects, patent ductus arteriosus, hypoplastic left heart or pulmonary valve atresia (Jenkins et al.,
2009; Perdu et al., 2010). Other abnormalities associated with OSCS include intestinal malrotation,
nervous system malformation, hydronephrosis, and limb hypoplasia (Jenkins et al., 2009; Rott et
al., 2003; Perdu et al., 2010; Holman et al., 2011). This condition also predisposes surviving
patients to other medical problems in the future. Acquired hearing loss, facial paralysis and other
neurologic defects can occur as a result of compression of cranial nerves due to increased
ossification of the skull. Patients commonly experience developmental delay. OSCS has also
shown to be associated with epileptic seizures (Rott et al., 2003). Rare documented associations
of OSCS also include hypothyroidism, pyloric stenosis, increased bone fragility, and chronic lower
extremity pain in the absence of fractures (Rott et al., 2003; Nakamura et al., 1985; Fradin et al.,
2016; Ward et al., 2004). There has also been a documented case of genetic mosaicism in OSCS
(Joseph et al., 2010).
Due to the nonspecific and variable presentation of this condition, it is crucial for OSCS to
be diagnosed early to initiate proper management in a timely manner in order to improve patient
outcomes. Proper diagnosis is dependent on genetic analysis and identification of the AMER1
pathogenic variant. This case characterizes a patient who presented with multiple congenital
abnormalities but underwent a delay in receiving genetic testing due to healthcare disparities in an
underserved region of the United States, before ultimately being diagnosed with OSCS.
Case Presentation
A 7-month-old male was brought to a primary care pediatrician as a new patient. Upon
examination, the child had a large soft anterior fontanelle, apparent macrocephaly, and frontal
bossing along with a mild distal penile hypospadias. He demonstrated developmental delay as he
was unable to hold his head up or roll over, and only sat upright with tripoding. The child’s head
circumference was measured at 51.5 cm, in the 99.9th percentile for his age group. A CT scan of
the head demonstrated mild prominence of extra-axial cerebrospinal fluid spaces along the
frontoparietal lobes and minimal prominence of the lateral ventricles.
The patient was born at a gestational age of 39 weeks and 1 day by normal spontaneous
vaginal delivery to a gravida 7 para 6 mother. Prenatal ultrasound had revealed polyhydramnios,
suspected macrosomia, and bilateral choroid plexus cysts. On newborn exam, the child was noted
to have small ears and macrocephaly. Neonatal ultrasound of the head showed normal ventricles
and small bilateral choroid plexus cysts. Records for the patient’s previous well child visits at a
different clinic noted unspecified developmental delay at four months of age.
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After considering the patient’s birth and developmental history along with his multiple
unexplained congenital anomalies and imaging findings, the primary care pediatrician decided to
refer the patient to neurosurgery, who, after evaluation, described the macrocephaly and extraaxial fluid collection as benign. As care continued, the patient’s development was as follows: he
was able to roll over by 9 months of age; sit upright, pull to stand, and speak first words by 12
months; and crawl by 15 months of age. Head circumference was 51.8 cm (99.9th percentile) at 9
months of age and 53.6 cm at 18 months (99.9th percentile) indicating persistent macrocephaly.
The patient’s continued evaluation included several diagnostic studies over the course of
his first two years of life. MRI of the head at 11 months of age showed no evidence of
hydrocephalus. At 14 months, the child was noted to have an elevated serum creatine kinase level
of 239 U/L (reference range < 160 U/L). A chromosomal microarray detected a 72 kb deletion of
chromosome 2q37.3 within the intron of the HDAC4 gene. The patient was referred to a geneticist
for further evaluation. The child resided in a county classified by the U.S. Department of
Agriculture as a “2” on the Rural-Urban continuum and had to be referred to a larger urban
academic center over 400 miles away from his residence for further evaluation. Transportation to
this distant facility was an apparent issue, as was scheduling due to this being the only such facility
in the entire state. As such, the patient was not seen for further genetic evaluation until over three
months later. The provider at the genetic center recommended exome sequencing along with
parental testing. Six additional months later, exome sequencing results returned and revealed a de
novo pathogenic variant, c.1215_1221del (p.Leu406Ilefs*14), in the AMER1 gene. The child was
diagnosed with Osteopathia Striata with Cranial Sclerosis. Due to the patient’s limited access to
genetic services, the patient was not diagnosed until he neared 2 years of age, even though the
initial referral for genetic evaluation was placed nine months before.
DISCUSSION
This patient presented with multiple unexplained congenital abnormalities and
developmental delay at 7 months of age and a genetic condition was suspected. Due to travel
distances, long wait periods for appointments, financial restrictions, and limited accessibility and
availability of genetic counselors in the patient’s region of residence, he experienced a protracted
process of genetic testing before being diagnosed with OSCS. Due to the nonspecific and variable
presentation of OSCS, genetic testing is a pivotal component of patient care as a definitive
diagnosis prepares the patient, family, and healthcare providers with knowledge of what to expect
over the course of the patient’s life and helps guide patient management. Prior knowledge of a
genetic condition in this family could have led to targeted intervention and appropriate
management of the patient from birth. However, the patient’s limited accessibility to genetic
testing led to a delay in diagnosis, and he was temporarily lost to follow-up as a consequence of
the extensively prolonged workup.
The significance of genetic testing extends beyond the patient as it may impact immediate
family members who undergo testing as well. Parental testing can influence future family planning,
especially considering the associated risk of in utero fetal demise in OSCS. The patient’s mother
in this case suffered a miscarriage in the past and experienced another one soon after the birth of
this patient. The exact etiology of those miscarriages is unknown; however, it is possible the
genetic association of OSCS may have been an underlying factor. Prior knowledge of this genetic
condition may have been a determining factor in future conceptions for this family, highlighting
the broader implications of access to genetic testing.
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Genetic variation or abnormality affects an estimated 8% of all live births (Kim &
Bodurtha, 2019). Approximately 26% of infants with three or more minor congenital abnormalities
have associated major abnormalities (Leppig et al., 1987). Consequently, genetic testing is now
being incorporated into preventative medicine and World Health Organization screening
guidelines for providers (Fogleman et al., 2019). However, the referral process, long wait times
for appointments, travel distances, and time taken to receive results can make genetic testing a
significantly drawn-out process. This problem is amplified in rural communities in the United
States with limited access to geneticists.
The healthcare deficits in rural areas has been well-documented in primary literature (Hall
& Olopade, 2006; US Department of Health and Human Services, Health Resources and Services
Administration, Maternal and Child Health Bureau, 2015). Rural areas are especially lacking in
genetic counseling services, which greatly affects the early diagnosis of pediatric genetic disorders
Emmet et al., 2017). While technical advances have made clinical genetic testing more cost
effective, genetic counseling is still difficult to access for patients. Although several studies have
shown rural patients are receptive to counseling in any form, whether in person or through
telemedicine services, the supply has yet to meet the demand (Fogleman, 2019; Cohen et al., 2013).
These issues affect the rural populace as a whole, but it is especially important to consider the
consequences that the lack of genetic counseling services has on the pediatric population in
particular. There has been a nationwide decline in pediatric mortality in the US since 1999, but a
recent study has shown that children in rural areas have not seen that same decline in mortality
(Probst et al., 2019). Difficulties in obtaining genetic counseling and other similar highly technical
services contribute to this multifactorial problem.
This case reflects the many patients and families who are impacted by the limited
accessibility of specialty services such as genetic counseling nationwide, leading to inadequate
medical care. It highlights the importance of further research and investment into making these
services more accessible for pediatric patients, especially in rural settings, to prevent delays in
diagnosis and guide patient management.
CONCLUSION
OSCS is a rare genetic disorder that is diagnosed in early childhood and is associated with
multiple comorbidities that increase the risk of developmental abnormalities. Early genetic
counseling is paramount to evaluate for suspected OSCS and its associated genetic abnormalities.
Limited access to genetic services is a significant barrier to healthcare for many patients, and this
problem is only amplified in rural and underserved areas which may lack the services of other
pediatric specialties as well. This limited access makes early diagnosis exceptionally more
difficult, which can affect both the patient’s healthcare outcomes as well as that of the patient’s
family. Awareness of this disparity is imperative, and measures need to be taken to make pediatric
specialty services more accessible to those in rural environments in order to prevent a delay in
diagnosis which may lead to adverse health outcomes. As access to a geneticist in rural or
underserved areas can take many months if available, it is important that pediatric healthcare
providers such as pediatricians and family practitioners are appropriately trained in matters
regarding the evaluation and management of patients with dysmorphology and have access to
further training regarding genetic counseling and evaluation of patients. Going forward,
telemedicine may also play a role in addressing some of these barriers for genetic evaluation in
underserved areas and is an option to consider in the future.
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